All Stories

  1. Multi-site screening for Pneumocystis jirovecii in lung cancer: possible tumour tissue colonization
  2. Helminth Immune Modulation and Invasive Fungal Infections in Sub-Saharan Africa
  3. Ten-Year Trends in Clinical Profiles, Management, and Outcomes of De Novo Acute Heart Failure
  4. Genetic patterns related to von Willebrand factor: implications on the need for mechanical ventilation, severity, and death in COVID-19
  5. Effectiveness of Urea and Tolvaptan in the Treatment of Hypotonic Hyponatremia
  6. Pneumocystis Infection in Pregnant Women: A Scoping Review
  7. Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
  8. Spanish consensus on managing pregnancy in women with Gaucher disease
  9. Pathogens of Medical Importance Identified in Hospital-Collected Cockroaches: A Systematic Review
  10. Proteomic Approach to Study the Effect of Pneumocystis jirovecii Colonization in Idiopathic Pulmonary Fibrosis
  11. Pathogens of Medical Importance Identified in Hospital-Collected Cockroaches: A Systematic Review
  12. The Impact of the Second Wave of the COVID-19 Pandemic on Non-COVID Hospital Care in a Tertiary Hospital in Spain
  13. La ecografía virtual en la formación en el grado en Medicina
  14. Genetic and Morphological Identification of Spirometra decipiens in Snakes and Domestic Dog Found in Cuba
  15. Nonspecific Effects of Infant Vaccines Make Children More Resistant to SARS-CoV-2 Infection
  16. Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa
  17. Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation
  18. Multilocus Genotyping of Pneumocystis jirovecii from Deceased Cuban AIDS Patients Using Formalin-Fixed and Paraffin-Embedded Tissues
  19. Triplex Hybridization-Based Nanosystem for the Rapid Screening of Pneumocystis Pneumonia in Clinical Samples
  20. Fast and Accurate Pneumocystis Pneumonia Diagnosis in Human Samples Using a Label-Free Plasmonic Biosensor
  21. The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
  22. Guía de práctica clínica multidisciplinar española sobre la enfermedad de Anderson-Fabry en adultos. I: Método y recomendaciones
  23. Tratamiento anticoagulante en pacientes médicos con situaciones clínicas complejas
  24. Infección por Pneumocystis jirovecii en pacientes con neumonía intersticial aguda
  25. Consenso Delphi-RAND de la Sociedad Española de Medicina Interna sobre controversias en terapia y profilaxis anticoagulante en enfermedades médicas. Proyecto INTROMBIN (INcertidumbre en TROMBoprofilaxis en Medicina INterna)
  26. Evidence of the Red-Queen Hypothesis from Accelerated Rates of Evolution of Genes Involved in Biotic Interactions in Pneumocystis
  27. Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: A cross-sectional survey
  28. Human T-Lymphotropic Virus Infection in Hepatitis C Virus–Antibody Positive Patients in Spain
  29. Pneumocystis jirovecii and Cystic Fibrosis in Brittany, France
  30. Human T-lymphotropic virus type 1 infection and disease in Spain
  31. Importance of tissue sampling, laboratory methods, and patient characteristics for detection of Pneumocystis in autopsied lungs of non-immunosuppressed individuals
  32. Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study
  33. Early Acquisition of Pneumocystis jirovecii Colonization and Potential Association With Respiratory Distress Syndrome in Preterm Newborn Infants
  34. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
  35. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study
  36. GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
  37. Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia
  38. Apparent Absence of Pneumocystis Jirovecii Colonization in Cuban HIV-infected Children and Adolescents
  39. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia
  40. The 13th International Workshops on Opportunistic Protists (IWOP13)
  41. Adecuación de tromboprofilaxis en pacientes médicos hospitalizados en Andalucía. Estudio multicéntrico
  42. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers
  43. AIDS-related Pneumocystis jirovecii genotypes in French Guiana
  44. Serum and bal beta-d-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients
  45. High prevalence of Pneumocystis jirovecii colonization among HIV-positive patients in southern Brazil
  46. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
  47. Pneumocystisand Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries – a mini-review
  48. Genetic diversity of Pneumocystis jirovecii in colonized Cuban infants and toddlers
  49. Attitudes and Perceptions about Clinical Guidelines: A Qualitative Study with Spanish Physicians
  50. Use of clinical practice guidelines and factors related to their uptake: a survey of health professionals in Spain
  51. Prevalence and Genotype Distribution of Pneumocystis jirovecii in Cuban Infants and Toddlers with Whooping Cough
  52. Pneumocystis jiroveciipneumonia in Latin America. A public health problem?
  53. The 12th International Workshops on Opportunistic Protists (IWOP-12)
  54. High prevalence ofPneumocystis jiroveciicolonization in Brazilian cystic fibrosis patients
  55. Low genetic diversity ofPneumocystis jiroveciiamong Cuban population based on two-locus mitochondrial typing
  56. Highly pathogenic avian influenza virus H5N1 controls type I IFN induction in chicken macrophage HD-11 cells: a polygenic trait that involves NS1 and the polymerase complex
  57. Pneumocystis jirovecii colonization in patients treated with infliximab
  58. Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey
  59. Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization
  60. Pneumocystisinfection in humans: diagnosis and treatment
  61. Pneumocystisinfection: unraveling the colonization-to-disease shift
  62. PneumocystisInfection: Seeing beyond the Tip of the Iceberg
  63. El ser humano como reservorio de Pneumocystis
  64. Epidemiology of Pneumocystis infection in Human
  65. Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens
  66. Seroprevalence of HTLV-1/2 Infection among Native and Immigrant Pregnant Women in Spain
  67. Prevalence of dihydropteroate synthase mutations in Spanish patients with HIV-associated Pneumocystis pneumonia
  68. HypotheticalPneumocystis jiroveciiTransmission from Immunocompetent Carriers to Infant
  69. Vertical Transmission ofPneumocystis jiroveciiin Humans
  70. Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization
  71. Profilaxis de la enfermedad tromboembólica venosa: ¿una asignatura pendiente?
  72. Pneumocystis jiroveciiTransmission from Immunocompetent Carriers to Infant
  73. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain
  74. Antiphospholipid antibodies investigation in Pneumocystis jirovecii carriers
  75. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients
  76. Short Communication: Hospital-Based Surveillance for HTLV-1/2 Infections in Spain
  77. Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease Who Are Colonized with Pneumocystis jiroveci
  78. Infección por el virus de la inmunodeficiencia humana tipo 2 y virus linfotrópicos humanos tipos 1 y 2 en España
  79. Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I
  80. Comparison of Single and Touchdown PCR Protocols for Detecting Pneumocystis jirovecii DNA in Paraffin-Embedded Lung Tissue Samples
  81. Usefulness Of Oropharyngeal Washings For Identifying Pneumocystis jirovecii Carriers
  82. Occurrence of bacterial indicators and bacteriophages infecting enteric bacteria in groundwater in different geographical areas
  83. Pneumocystis jirovecii: un nuevo nombre para un viejo patógeno
  84. Polymorphisms inPneumocystis jiroveciiStrains in Spanish Children with Cystic Fibrosis
  85. Pneumocystis jirovecii colonisation in patients with interstitial lung disease
  86. Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain
  87. Work, career satisfaction, and the position of general internists in the south of Spain
  88. Risk of venous thromboembolic disease in women
  89. Efectividad de la implantación de una guía clínica sobre la angina inestable mediante una estrategia multifactorial. Ensayo clínico aleatorizado en grupos
  90. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain
  91. Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain
  92. High seroprevalence of Pneumocystis infection in Spanish children
  93. Climatic factors and Pneumocystis jiroveci infection in southern Spain
  94. Epidemiology of Pneumocystis carinii pneumonia in southern Spain
  95. Pneumocystis jiroveci Genotypes in the Spanish Population
  96. Resistencia genotípica a sulfamidas en pacientes con neumonía por Pneumocystis jiroveci
  97. Infecciones por VIH-2 y HTLV-I/II en España
  98. Association between human-Pneumocystis infection and small-cell lung carcinoma
  99. Cosmopolitan HTLV-Ia Subtype Among Spanish Native Patients
  100. Lymphocyte Response in Subjects with Chronic Pulmonary Disease Colonized by Pneumocystis jirovecii
  101. Seroprevalence of Pneumocystis Human Infection in Southern Spain
  102. Primary lymphoma of the central nervous system and HTLV-I infection
  103. Candesartan and acute liver injury
  104. Prevalence of HTLV infection in pregnant women in Spain
  105. Enoxaparin for the Prevention of Venous Thromboembolism
  106. Absence of Pneumocystis carinii Carriers among Patients with Cystic Fibrosis
  107. Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype
  108. Significance of indeterminate reactivity to human T-Cell lymphotropic virus in Western blot analysis of individuals at risk
  109. Presence of glomerular basement membrane (GBM) antibodies in HIV−patients with Pneumocystis carinii pneumonia
  110. Epidemiology of HIV-2 infection in Spain
  111. HTLV-I-Associated Illnesses in Spain
  112. Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain
  113. Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients
  114. Avoiding false-negative results for HTLV-II using new serological assays
  115. CD4+ T-lymphocytopenia in the elderly
  116. Does Early Zidovudine Treatment Prevent The Emergence Of Syncytium-Inducing Human Immunodeficiency Virus?
  117. HTLV-I and HTLV-II Infections in Spain
  118. HTLV-I/II Infections in Spain
  119. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of seville, Spain
  120. Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain